Tseligkaridou, Georgia
Egger, Stephan T.
Spiller, Tobias R.
Schneller, Lena
Frauenfelder, Fritz
Vetter, Stefan
Seifritz, Erich
Burrer, Achim
Article History
Received: 29 January 2023
Accepted: 17 March 2023
First Online: 28 March 2023
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the Canton of Zurich (BASEC-Nr. 2021 − 01246). Patient consent was waived due to approval by the Ethics Committee of the Canton of Zurich.
: Not applicable.
: ES received in the last three years honoraria and grants for advice and educational lectures from Lundbeck Switzerland, Schwabe Switzerland and Germany, Janssen Switzerland, Otsuka Pharmaceutical Switzerland, Mepha Pharma Switzerland, Recordati Switzerland and Sunovion Pharma United Kingdom and Angelini. AB received speaking fees from Recordati. The other authors declare that they have no competing interests in this section.